168 related articles for article (PubMed ID: 30864554)
1. Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus.
Xiao JP; Wang XR; Zhang S; Wang J; Zhang C; Wang DG
Iran J Immunol; 2019 Mar; 16(1):43-52. PubMed ID: 30864554
[TBL] [Abstract][Full Text] [Related]
2. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases.
Ding S; Zhou H; Gu Y; Shen Y; Zhang L; Zhao H; Wu J; Zhang X; Chang X; Liu C
Clin Exp Immunol; 2021 Aug; 205(2):150-159. PubMed ID: 33961296
[TBL] [Abstract][Full Text] [Related]
4. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J
World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
Zhang C; Li Y; Wang Y
J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranes.
Mach P; Köninger A; Wicherek L; Kimmig R; Kasimir-Bauer S; Birdir C; Schmidt B; Gellhaus A
Am J Reprod Immunol; 2016 Aug; 76(2):149-54. PubMed ID: 27302185
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Blood Serum Levels of the Costimulatory Soluble B7-H4 Molecule in Pregnant Women During the Peripartal Phase.
Mach P; Gellhaus A; Wicherek L; Schmidt B; Kimmig R; Kasimir-Bauer S; Köninger A
Am J Reprod Immunol; 2015 Sep; 74(3):209-15. PubMed ID: 25907449
[TBL] [Abstract][Full Text] [Related]
10. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
11. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
12. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
13. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
Xu C; Qian L; Yu L; Zhang X; Wang Q
Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
[TBL] [Abstract][Full Text] [Related]
16. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
AlFadhli S; AlFailakawi A; Ghanem AA
Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
20. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]